C. Maschi

发表

Dose-response and normal tissue complication probabilities after proton therapy for choroidal melanomas.

J. Thariat, J. Herault, J. Kiilgaard, 2020, Ophthalmology.

Small but Challenging Conjunctival Melanoma: New Insights, Paradigms and Future Perspectives

C. Bertolotto, P. Hofman, S. Baillif, 2021, Cancers.

Swept-source and spectral domain OCT imaging of conjunctival tumors.

S. Baillif, S. Lassalle, C. Maschi, 2020, Ophthalmology.

Multicenter, International Assessment of the Eighth Edition of the American Joint Committee on Cancer Cancer Staging Manual for Conjunctival Melanoma

B. Gallie, H. Heimann, B. Damato, 2019, JAMA ophthalmology.

[Benign conjunctival tumors].

C. Maschi, J. Caujolle, I. Liolios, 2013, Journal francais d'ophtalmologie.

Dose-response and normal tissue complication probabilities after proton therapy for choroidal melanomas Dose response after proton therapy for choroidal melanoma

J. Thariat, J. Kiilgaard, A. Appelt, 2021 .

Dry Eye Syndrome After Proton Therapy of Ocular Melanomas.

J. Thariat, J. Salleron, J. Herault, 2017, International journal of radiation oncology, biology, physics.

Uveitis associated with latent tuberculosis: A comparative study of the impact of antitubercular therapy combined or not with systemic corticosteroids

S. Baillif, C. Maschi, N. Tieulié, 2020, European journal of ophthalmology.

Outcomes After Proton Beam Therapy for Large Choroidal Melanomas in 492 Patients.

J. Thariat, J. Herault, S. Baillif, 2016, American journal of ophthalmology.

Ultra‐widefield fundus photography for radiation therapy planning of ocular tumours

J. Thariat, J. Herault, L. Kodjikian, 2020, Acta ophthalmologica.

Visual Outcomes of Parapapillary Uveal Melanomas Following Proton Beam Therapy.

J. Thariat, J. Herault, W. Sauerwein, 2016, International Journal of Radiation Oncology, Biology, Physics.

Clinical Investigation : Central Nervous System Tumor Local Recurrence After Uveal Melanoma Proton Beam Therapy : Recurrence Types and Prognostic Consequences

P. Gastaud, J. Herault, E. Chamorey, 2022 .

OCT-angiography for the diagnosis of radiation maculopathy in patients treated with proton beam therapy: A 2-year prospective study

S. Baillif, C. Maschi, J. Caujolle, 2021, European journal of ophthalmology.

Mascara deposits in an anophthalmic socket mimicking a conjunctival melanoma.

S. Baillif, S. Lassalle, C. Maschi, 2020, Journal francais d'ophtalmologie.

The molecular pathology of eye tumors: A 2019 update Main interests for routine clinical practice.

P. Hofman, S. Baillif, S. Lassalle, 2019, Current molecular medicine.

Management of Invasive Squamous Cell Carcinomas of the Conjunctiva.

J. Thariat, J. Salleron, J. Herault, 2019, American journal of ophthalmology.

[Surgery and additional protontherapy for treatment of invasive and recurrent squamous cell carcinomas: technique and preliminary results].

P. Gastaud, J. Herault, P. Chauvel, 2009, Journal francais d'ophtalmologie.

Oncologic and visual outcomes after postoperative proton therapy of localized conjunctival melanomas

J. Thariat, J. Salleron, J. Herault, 2019, Radiation Oncology.

Conjunctival melanoma copy number alterations and correlation with mutation status, tumor features, and clinical outcome

H. Heimann, B. Damato, A. Taktak, 2019, Pigment cell & melanoma research.

[Malignant tumours of the eye: Epidemiology, diagnostic methods and radiotherapy].

J. Thariat, W. Sauerwein, C. Maschi, 2015, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Conjunctival melanoma treatment outcomes in 288 patients: a multicentre international data-sharing study

B. Gallie, H. Heimann, B. Damato, 2020, British Journal of Ophthalmology.

The liquid biopsy: a tool for a combined diagnostic and theranostic approach for care of a patient with late-stage lung carcinoma presenting with bilateral ocular metastases

C. Marquette, J. Thariat, P. Hofman, 2017, Expert review of anticancer therapy.

Tumour Response in Uveal Melanomas Treated with Proton Beam Therapy.

J. Thariat, J. Herault, C. Maschi, 2016, Clinical oncology (Royal College of Radiologists (Great Britain)).

Single-cell RNA sequencing reveals intratumoral heterogeneity in primary uveal melanomas and identifies HES6 as a driver of the metastatic disease

K. Bille, C. Bertolotto, R. Ballotti, 2021, Cell Death & Differentiation.

Single-cell RNA sequencing reveals intratumoral heterogeneity in 3 primary uveal melanomas and identi fi es HES 6 as a driver of the 4 metastatic disease

K. Bille, C. Bertolotto, R. Ballotti, 2021 .

Management of choroidal metastases.

J. Thariat, P. Marcy, J. Herault, 2014, Cancer treatment reviews.

Acute macular neuroretinopathy: contribution of spectral-domain optical coherence tomography and multifocal ERG

P. Gastaud, C. Maschi, V. Paoli, 2011, Graefe's Archive for Clinical and Experimental Ophthalmology.

Diagnosis and treatment of peripheral exudative haemorrhagic chorioretinopathy

G. Quentel, J. Thariat, R. Tadayoni, 2019, British Journal of Ophthalmology.

Cataract Avoidance With Proton Therapy in Ocular Melanomas.

J. Thariat, J. Salleron, J. Herault, 2017, Investigative ophthalmology & visual science.

COMPARATIVE EFFECTIVENESS OF PROTON BEAM VERSUS PHOTODYNAMIC THERAPY TO SPARE THE VISION IN CIRCUMSCRIBED CHOROIDAL HEMANGIOMA.

J. Thariat, J. Salleron, J. Herault, 2020, Retina.

Mechanisms of phosphenes in irradiated patients

J. Thariat, J. Herault, L. Kodjikian, 2017, Oncotarget.

INTRAVITREAL DEXAMETHASONE 0.7-MG IMPLANT FOR RADIATION MACULAR EDEMA AFTER PROTON BEAM THERAPY FOR CHOROIDAL MELANOMA

P. Gastaud, S. Baillif, C. Maschi, 2013, Retina.

A noninterventional study to monitor patients with diabetic macular oedema starting treatment with ranibizumab† (POLARIS)

J. Sahel, S. Sivaprasad, B. Lorenz, 2018, Acta ophthalmologica.

Dry eye syndrome following proton therapy of ocular melanomas

J. Thariat, J. Herault, S. Baillif, 2016 .

The Lens Opacities Classification System III Grading in Irradiated Uveal Melanomas to Characterize Proton Therapy-Induced Cataracts.

J. Thariat, J. Salleron, J. Herault, 2019, American journal of ophthalmology.

Proton Beam Therapy for Iris Melanomas in 107 Patients.

J. Thariat, J. Salleron, J. Herault, 2017, Ophthalmology.

Inverted conjunctival papilloma: a certainly underestimated high-risk lesion for carcinomatous transformation-a case report.

P. Hofman, V. Giordanengo, S. Lassalle, 2017, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[Management of uveal melanomas, guidelines for oncologists].

L. Desjardins, J. Thariat, J. Herault, 2018, Bulletin du cancer.

Occurrence of Phosphenes in Patients Undergoing Proton Beam Therapy for Ocular Tumor.

J. Thariat, J. Herault, L. Kodjikian, 2018, American journal of ophthalmology.

Phosphenes in patients receiving radiotherapy.

J. Thariat, J. Herault, S. Baillif, 2016, The Lancet. Oncology.

Use of hydroxychloroquine in corticodependent and recurrent scleritis

P. Gastaud, S. Baillif, C. Maschi, 2013, Graefe's Archive for Clinical and Experimental Ophthalmology.

Visual Outcomes of Parapapillary Uveal Melanomas Following Proton Beam Therapy.

J. Thariat, J. Herault, W. Sauerwein, 2016, International journal of radiation oncology, biology, physics.

[Management of uveal melanomas, guidelines for oncologists].

L. Desjardins, J. Thariat, J. Herault, 2018, Bulletin du cancer.

[Benign conjunctival tumors].

C. Maschi, J. Caujolle, I. Liolios, 2013, Journal francais d'ophtalmologie.

Treatment of Neovascular Glaucoma after Proton Therapy for Uveal Melanomas with Ranibizumab Injection: Preliminary Results

P. Gastaud, G. Pagès, C. Maschi, 2011, Ophthalmic Research.